ARS Pharmaceuticals - SPRY Company Short-Term Debt

Public company logo of ARS Pharmaceuticals, Inc. (SPRY)

ARS Pharmaceuticals generates revenue through the sale of advanced emergency care products, headlined by its non-injectable epinephrine spray for anaphylaxis. The business relies on global distribution partnerships, which bolster international sales through joint alliances. The current figure is 0.00. A stable team of scientists and low employee turnover support development, and a visual snapshot of the price action for a specific debt instrument is presented below.

SPRY (ARS Pharmaceuticals Inc) Company Short-Term Debts history from 04/28/2023 to 10/28/2026

SPRY (ARS Corp): analytical breakdowns and indicator data

- price and consensus price forecast:
Price Chart ARS Pharmaceuticals, Inc.|SPRY - Fair Value Consensus
- market capitalization data:
Market Value ARS Pharmaceuticals, Inc.|SPRY - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share ARS Pharmaceuticals|SPRY - Book Capitalization|Market Cap to Net Assets Ratio ars-pharma.com|SPRY - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity ARS Pharmaceuticals|SPRY - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio ARS Pharmaceuticals|SPRY - Company Cumulative Indebtedness|Debts to Book Capitalization ARS Pharmaceuticals, Inc.|SPRY - Company Long-Term Loans and Borrowings|Company Short-Term Debts ARS Pharmaceuticals
Analysis of all company metrics:SPRY ARS Pharmaceuticals, Inc.
Finished products of ars-pharma.com

ARS Pharmaceuticals is investing in the market launch of innovative nasal sprays for emergency allergy therapy. Short-term loan volume dynamics digitize the company's current liabilities with maturities of up to one year. This metric measures liquidity and the risk of cash flow gaps by filtering out temporary noise. Reducing the debt load minimizes financial risks but limits credit leverage. Analyzing short-term loan volume allows for an assessment of the issuer's capital stability.

Competitors of ARS Pharmaceuticals (SPRY)

Company Short-Term Debt Haleon (HLN)|KVUE: Company Short-Term Loans and Borrowings|VRNA (Verona Pharma Corp) - Company Short-Term Debt|Jyong Bio (MENS) - Company Current Liabilities|LGND (Ligand Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts amneal.com (AMRX)|Perrigo (PRGO) - Company Current Liabilities|Company Short-Term Loans and Borrowings ALVO (Alvotech S.A.)|LQDA: Company Short-Term Debt|GLPG - Short-Term Debt|Company Current Liabilities ANI Pharmaceuticals ANIP|MNKD - Amount of Current Liabilities|Company Short-Term Debts Amphastar Pharmaceuticals, Inc. AMPH|Pacira Pharmaceuticals (PCRX) - Company Short-Term Loans and Borrowings|Company Short-Term Debts TBPH (Theravance)|Short-Term Debt AQST|scPharmaceuticals Inc. (SCPH) - Company Short-Term Debt|Company Short-Term Loans and Borrowings tectonictx.com (TECX)|Company Short-Term Debts TNXP (Tonix Pharmaceuticals Holding Corp.)|SXT Pharmaceuticals - Company Short-Term Debts|Company Short-Term Debt Eupraxia Pharma (EPRX)|BHST: Company Short-Term Loans and Borrowings|eXoZymes Inc - Company Short-Term Debt|Short-Term Debt Volume Oramed Pharmaceuticals Inc.|ENTX - Company Current Liabilities|Company Short-Term Loans and Borrowings HYFT|ABVC - Company Short-Term Debt|Current Liabilities Cumberland Corp (CPIX)|Company Short-Term Debts Quantum BioPharma Ltd|Company Short-Term Loans and Borrowings fibrogen.com FGEN|Telomir Pharmaceuticals, Inc. - Company Short-Term Debts|RANI: Company Short-Term Debts|Company Short-Term Debt synergychc.com SNYR|RLYB (Rallybio) - Company Short-Term Loans and Borrowings|Company Short-Term Debt LEXX|Company Current Liabilities pulmatrix.com|Company Short-Term Debts PTHL|Company Short-Term Debts aptorumgroup.com (APM)|Lyra Therapeutics, Inc - Company Short-Term Debts|Company Current Liabilities impactbiomedinc.com IBO|TNFA (TNF Pharma) - Company Short-Term Debts|cbdMD, Inc. (YCBD) - Short-Term Debt|PRFX: Company Current Liabilities|Company Short-Term Debts Altamira Therapeutics Ltd.|Lipella (LIPO) - Company Current Liabilities|Amount of Current Liabilities OptiNose Corp|PIRS (Pieris Pharmaceuticals) - Company Short-Term Debts|Short-Term Debt Volume procapsgroup.com (PROC)|Petros Pharmaceuticals, Inc. - Company Short-Term Debts|Company Current Liabilities Qilian International Holding Group QLI|ACELYRIN, Inc. - Company Short-Term Debts|TFFP: Company Short-Term Debts